Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Michael Retsky

Achievements

2017Scientific book editor: Co-edited Perioperative Inflammation as Triggering Origin of Metastasis Development, published by Springer Nature
—

Dr. Michael Retsky

Hon Associate Prof at University College London

University College London (UCL), United Kingdom

About

Dr. Michael W. Retsky is a physicist turned cancer researcher whose work focuses on tumor growth, cancer recurrence, metastasis, and the biological processes that influence the progression of breast cancer. His interdisciplinary career combines mathematical modelling, computational analysis, experimental research, and clinical data to investigate how cancer develops and why it may recur after treatment.

Dr. Retsky earned his PhD in experimental physics from the University of Chicago in 1974. His doctoral research involved the development of a scanning transmission electron microscope capable of resolving individual atoms and measuring their scattering properties. His early career included electron optics research at Hewlett-Packard, where he developed expertise in physics, quantitative analysis, and computational methods.

His transition into cancer research began in the early 1980s, when he joined an informal research group investigating cancer growth and treatment outcomes. Drawing on his background in physics and computer simulation, he began examining clinical data on breast cancer recurrence. His early oncology research contributed to the hypothesis that breast cancer growth can include periods of dormancy, during which cancer cells or small metastatic deposits remain relatively inactive before becoming clinically detectable.

Dr. Retsky subsequently held academic and research appointments at the University of Colorado, the University of Texas, and Harvard Medical School, where he worked with the late Professor Judah Folkman and his research team. He has also been affiliated with Harvard T.H. Chan School of Public Health and University College London, where he has been listed as an honorary associate professor in the Division of Surgery and Interventional Science.

A central focus of his research is the relationship between primary cancer surgery, inflammation, and the subsequent development of metastatic disease. Working with international collaborators, he has investigated whether the physiological response to surgery may influence the growth of previously dormant cancer cells in some patients. His publications have explored the timing of breast cancer recurrence and the potential role of perioperative anti-inflammatory interventions in reducing recurrence risk. These ideas remain subjects of ongoing scientific investigation and should be understood as research hypotheses rather than established explanations for all cancer recurrence.

Dr. Retsky has collaborated with researchers including Romano Demicheli, William Hrushesky, Michael Baum, and Isaac Gukas. Their work has examined patterns of cancer recurrence, tumor dormancy, and mathematical models of metastatic growth. He has co-edited the scientific book Perioperative Inflammation as Triggering Origin of Metastasis Development, published by Springer Nature in 2017, which explores the possible relationship between inflammation surrounding surgery and the progression of metastatic disease.

In addition to his work on breast cancer, Dr. Retsky has been involved in research and professional discussions concerning colon cancer and cancer treatment strategies. Following his own diagnosis of stage III colon cancer in 1994, he pursued a low-dose, long-term chemotherapy approach that is now associated with the concept of metronomic chemotherapy. His personal experience further informed his interest in cancer biology and treatment, although his individual treatment history should not be interpreted as evidence that a particular approach is suitable for other patients.

Dr. Retsky has authored and co-authored numerous scientific publications in physics and oncology. His research has appeared in peer-reviewed journals and has been presented at international cancer research conferences. His work brings together concepts from physics, mathematical modelling, tumor biology, and clinical oncology to explore new ways of understanding cancer recurrence and identifying potential avenues for further research.

Achievements and Professional Contributions

  • Interdisciplinary research career: Transitioned from experimental physics to cancer research, applying quantitative and computational methods to problems in oncology.
  • Doctoral research in experimental physics: Earned a PhD from the University of Chicago in 1974, with research involving high-resolution electron microscopy.
  • Breast cancer recurrence research: Contributed to investigations of recurrence patterns, tumor dormancy, and metastatic disease development.
  • Research on surgery and inflammation: Co-authored studies examining the hypothesis that inflammation associated with primary surgery may influence the growth of dormant cancer deposits.
  • International research collaboration: Worked with researchers in oncology, surgery, mathematical modelling, and cancer biology.
  • Scientific book editor: Co-edited Perioperative Inflammation as Triggering Origin of Metastasis Development, published by Springer Nature in 2017.
  • Academic affiliations: Has held research and teaching affiliations with Harvard Medical School, Harvard T.H. Chan School of Public Health, and University College London.
  • Scientific publications: Has authored and co-authored peer-reviewed research in physics, breast cancer, tumor growth, and cancer recurrence.
  • Cancer research conference participation: Has served as a speaker and organizing committee member at international cancer research conferences.
  • Patient advocacy: Has been associated with the Colon Cancer Alliance, contributing to the wider cancer community through research and advocacy activities.

Education and Academic Background

  • PhD in Experimental Physics — University of Chicago, 1974.
  • Research experience in electron optics — Hewlett-Packard.
  • Academic and research appointments — University of Colorado, University of Texas, Harvard Medical School, Harvard T.H. Chan School of Public Health, and University College London.

Research Interests

  • Breast cancer recurrence and metastasis.
  • Tumor dormancy and metastatic growth.
  • Mathematical and computational modelling of cancer.
  • Surgery-associated inflammation and cancer progression.
  • Perioperative interventions and cancer outcomes.
  • Metronomic chemotherapy and treatment strategies.
  • Clinical data analysis in oncology.
  • Translational cancer research.

Professional Profile

Dr. Michael W. Retsky is a cancer researcher whose work bridges physics, computational modelling, and oncology. His research has focused on understanding the patterns of cancer recurrence and investigating the biological mechanisms that may contribute to metastatic progression.

Through his scientific publications, academic affiliations, and international research collaborations, he has contributed to continuing discussions about tumor dormancy, cancer recurrence, and the relationship between surgery and metastatic disease. His work is particularly relevant to researchers and healthcare professionals interested in breast cancer biology, translational oncology, and mathematical approaches to cancer research.

Events & Activities

18th International Conference on Pathology & Laboratory Medicine
Apr 12, 2027
Hybrid
Apr 12, 2027
Hybrid

18th International Conference on Pathology & Laboratory Medicine

Enquire for Cost

The 18th International Conference on Pathology & Laboratory Medicine will bring together pathologists, laboratory medicine specialists, researchers, clinicians, healthcare professionals, academics, students, and industry experts to exchange knowledge and explore the latest developments in diagnostic science. The conference will focus on modern pathology, laboratory medicine, histopathology, cytopathology, surgical pathology, clinical pathology, hematology, digital pathology, molecular diagnostics, and emerging technologies. It will provide a platform for scientific presentations, interactive discussions, networking, and collaboration among professionals from around the world. Join us in Prague, Czechia, on April 12–13, 2027, with virtual participation available, and be part of an international forum advancing diagnostic excellence and innovation in pathology and laboratory medicine.

UTILITARIAN EVENTS

  • 2 Days
  • Prague, Czechia
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education